Outset Medical, Inc. (OM) Stock

Outset Medical, Inc. (OM) is a Healthcare stock trading at $5.06 (as of 2026-06-18), with a market capitalization of $90.65M and a trailing P/E of -1.5. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

Outset Medical, Inc. develops a hemodialysis system, including the Tablo Hemodialysis System with a compact console, integrated water purification, on-demand dialysate production, and software and connectivity features. It supports dialysis care in acute and home settings.

Valuation — source: SEC EDGAR (first-party)
Price$5.06
Market Cap$90.65M
P/E Ratio-1.5
EV / EBITDA-2.2
Price / Book0.67
Price / Sales0.63
DCF Value (model)$-47.16
DCF Upside vs Price-1032.0%
Profitability & Growth — source: SEC EDGAR
Revenue (TTM)$119.48M
Net Margin-68.3%
Return on Equity-67.0%
Debt / Equity0.87
Current Ratio6.29
Revenue Growth (YoY)5.1%
EPS Growth (YoY)118.3%
FCF Growth (YoY)-59.8%
Financial Health — source: SEC EDGAR
Altman Z-Score-5.21 (distress)
Piotroski F-Score7/9 (strong)
Valuation vs Sector & Industry
Stock P/E-1.5
Sector P/E (Healthcare)21.0
Industry P/E (Medical Equipment)31.7
vs Sector-107.0%
vs Industry-104.6%
Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional HolderFMR LLC ($10.53M)
Institutional Holders Tracked10
Company
SectorHealthcare
IndustryMedical Equipment
CEOLeslie L. Trigg
Employees354
CountryUS
IPO Date2020-09-15

Related Companies (Business model: Medical Devices / Life Science Tools; 8 closest by market cap; US-domiciled)

  • DarioHealth Corp. (DRIO)
  • InspireMD, Inc. (NSPR)
  • Prenetics Global Limited (PRE)
  • Plus Therapeutics, Inc. (PSTV)
  • Sensus Healthcare, Inc. (SRTS)
  • HeartBeam, Inc. (BEAT)
  • Nutriband Inc. (NTRB)
  • Modular Medical, Inc. (MODD)
OM earnings history · OM institutional & insider holders · Congress trades · Insider trades · Short interest · Stock screener

Data as of 2026-06-18.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.